Structural Elucidation and Covalent Modulation of the Autorepressed Orphan Nuclear Receptor NR2F6

Guido J M Oerlemans1, Maxime C M van den Oetelaar1, Siebe P van den Elzen1

  • 1Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute of Complex Molecular Systems, Technische Universiteit Eindhoven, 5612 AZ Eindhoven, The Netherlands.

ACS Chemical Biology
|September 10, 2025
PubMed

Insights

Nuclear Receptor NR2F6 is a cancer immunotherapy target. Researchers elucidated its structure, revealing an autorepressed conformation and identifying covalent probes that inhibit coregulator recruitment, paving the way for novel cancer therapeutics.

Area of Science:

  • Molecular biology
  • Structural biology
  • Cancer research

Background:

  • The orphan nuclear receptor NR2F6 is a key target in cancer immunotherapy due to its roles in tumor growth and immune suppression.
  • Targeting NR2F6 offers a novel strategy for cancer treatment, but lacks molecular tools and structural data.
  • Understanding NR2F6's structure is crucial for developing effective modulators.

Purpose of the Study:

  • To elucidate the structure of the unliganded NR2F6 ligand binding domain (LBD).
  • To identify molecular strategies for targeting NR2F6 activity.
  • To provide a basis for developing novel NR2F6 modulators for cancer therapy.

Main Methods:

  • Co-crystallization of the NR2F6 LBD with a peptide from the Nuclear Receptor Binding SET Domain Protein 1 (NSD1).
  • Structural elucidation of the unliganded NR2F6 LBD using X-ray crystallography.
  • Screening of covalent NR probes to identify NR2F6 inhibitors.

Main Results:

  • The crystal structure revealed an autorepressed, homodimeric conformation of the NR2F6 LBD with helix 12 blocking the canonical coregulator binding site.
  • An alternative binding surface for NSD1 was identified in the apo-NR2F6 structure.
  • Covalent NR probes targeting a specific cysteine residue were found to inhibit NR2F6 coregulator recruitment.

Conclusions:

  • The study provides the first structural insights into the ligand-independent activity of NR2F6.
  • The identified NR2F6 structure and binding interactions can guide the development of new cancer drugs.
  • These findings represent a significant step towards creating novel NR2F6 modulators for cancer immunotherapy.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.4K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.4K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

3.0K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.2K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
10.8K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.2K